Skip to main content
. 2013 Sep 5;8(9):e73932. doi: 10.1371/journal.pone.0073932

Table 2. Clinical and Questionnaire Data.

Male (N = 41) Female (N = 225)
Variable Mean(SD) p-value(df) Mean(SD) p-value(df)
Age HC 34.04(11.23) p = 0.350(39) 29.48(3.56) p = 0.060(223)
IBS 35.39(11.04) 31.61(9.01)
Early adverse life events 1 HC 4.80(3.96) p = 0.075(37) 3.51(3.56) p = 0.041(208)
IBS 6.98(5.24) 4.47(3.95)
Anxiety 2 HC 3.19(2.94) p = 0.007(36) 3.59(2.98) p = 0.000(210)
IBS 5.75(4.45) 5.36(3.25)
Depression 3 HC 1.24(1.26) p = 0.011(36) 1.40(2.04) p = 0.000(210)
IBS 3.00(3.52) 2.65(2.55)
Somatization 4 HC 1.83(2.64) p = 0.033(11) 2.21(1.82) p = 0.000(143)
IBS 5.43(3.55) 5.68(3.40)
Trait Anxiety 5 HC 45.67(8.56) p = 0.016(38) 43.94(8.93) p = 0.000(221)
IBS 53.05(12.32) 51.37(9.76)
Catastrophizing 6 HC 0.19(0.39) p = 0.000(36) 0.38(0.73) p = 0.000(190)
IBS 1.09(0.88) 1.21(1.08)

Measures:

1

ETI global score;

2

HAD anxiety symptoms score;

3

HAD depression symptoms score;

4

PHQ score without IBS symptoms;

5

STAI raw score;

6

CSQ Catastrophizing score.

Groups: Healthy Controls (HC), Irritable bowel syndrome (IBS).